<DOC>
	<DOCNO>NCT02937025</DOCNO>
	<brief_summary>This study mainly evaluate feasibility safety kind Left Atrial Appendage Occluders prevent ischemic stroke cause nonvalvular atrial fibrillation ( AF )</brief_summary>
	<brief_title>Study Safety Efficacy Left Atrial Appendage Occulder</brief_title>
	<detailed_description>Atrial fibrillation ( AF ) common arrhythmia , incidence increase age . Thrombosis shed cause AF one major cause stroke . Most patient AF suffer ischemic stroke thrombosis leave atrial appendage ( LAA ) . The majority patient atrial fibrillation , blood clot come leave atrial appendage , close leave atrial appendage reduce cycle thromboembolism patient AF . Now patient cardiac surgery risk leave atrium related thromboembolism , surgery conventional perform leave atrial appendage close surgery . However , surgical leave atrial appendage ligation difficult completely close leave atrial appendage , internal medicine intervention method surgical closure leave atrial appendage relatively simple , minimally invasive , high success rate expect widely use . Several version LAA occlusion device developed.LAA occluder Shanghai Push Medical Device Technology CO.td , consist fix ball cover ; The fixed ball compose multiple umbrella cover ePTFE membrane.This study mainly evaluate feasibility safety new Left Atrial Appendage Occluder ! Through femoral vein puncture ; insert inter atrial septum puncture device ; puncture small hole atrial septal , delivery sheath insert femoral vein puncture site across atrial septal reach leave atrial appendage , establishment channel . Through built-channel sent LAA occluder leave atrial appendage delivery cable ; The LAA occlude fix leave atrial appendage , close entrance leave atrial appendage meanwhile block blood flow ; eliminate risk blood clot due atrial fibrillation , prevention stroke .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Patient ≥18 year age ; Chronic atrial fibrillation ≥3 month ; paroxysmal , persistent permanent nonvalvular AF ; CHADS2VAS score 2 higher，HASBLED score 3 high ; Patient understand trial purpose , voluntarily join clinical trial informed consent ; Patient voluntarily complete followup followup inspection accordance clinical trial process . 1 . A . Clinical exclusion criteria： Presence rheumatic , degenerative congenital valvular heart disease , The diameter leave atrial ≥65 mm ; LAA size &lt; 12mm &gt; 30 mm Left atrium remove ; Heart transplantation patient ; Symptomatic patient carotid artery disease ( carotid stenosis ≥ 50 % ) ; Acute myocardial infarction unstable angina ; Decompensated heart failure ( New York Heart Association functional class IIIIV ) ; Recent myocardial infarction ( &lt; 3 month ) ; Patients atrial septal defect receive atrial septal occluder . The patient ablation procedure plan within 30 day potential LAmbre Occluder implant The patient plan cardioversion 30 day post implant LAmbre Occluder Patient artificial mechanical heart valve replacement operation ; Uncontrolled Heart rate ≥ 110 beat / min17 ) History stroke TIA within 30 day ; Presence complex aortic plaque ( 4mm ) ascend aorta ; Cardiac tumor malignancy estimate life expectancy u less 2 year ; Have thrombocytopenia ( platelet 《105 / μl ) anemia（Hb &lt; 10g/dl） ; Women pregnancy plan pregnancy trial period ; Presence active sepsis endocarditis ; Patient participate trial ; The investigator expect patient able complete trial accord requirement . 2 . Esophageal ultrasonic exclusion criteria： LVEF≤30 % ; Presence leave atrial appendage thrombus ; High risk PFO patient ( presence atrial septal aneurysm ) ; Have obvious mitral valve stenosis ( area mitral valve≤ 2 cm2 ) ; Have obvious unexplained pericardial effusion ( ≥4 cm2 ) . Presence complex aortic plague ( ≥4 mm ) ascend aorta .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Nonvalvular atrial fibrillation</keyword>
	<keyword>Stroke</keyword>
	<keyword>Left Atrial Appendage Closure</keyword>
	<keyword>Intervention</keyword>
</DOC>